全文获取类型
收费全文 | 2096篇 |
免费 | 85篇 |
专业分类
耳鼻咽喉 | 25篇 |
儿科学 | 83篇 |
妇产科学 | 82篇 |
基础医学 | 158篇 |
口腔科学 | 52篇 |
临床医学 | 327篇 |
内科学 | 496篇 |
皮肤病学 | 90篇 |
神经病学 | 99篇 |
特种医学 | 35篇 |
外科学 | 286篇 |
综合类 | 84篇 |
一般理论 | 9篇 |
预防医学 | 150篇 |
眼科学 | 24篇 |
药学 | 154篇 |
肿瘤学 | 27篇 |
出版年
2017年 | 10篇 |
2015年 | 25篇 |
2014年 | 30篇 |
2013年 | 34篇 |
2012年 | 12篇 |
2011年 | 11篇 |
2010年 | 52篇 |
2009年 | 62篇 |
2008年 | 11篇 |
2007年 | 12篇 |
2005年 | 9篇 |
2003年 | 13篇 |
2001年 | 19篇 |
2000年 | 15篇 |
1999年 | 36篇 |
1998年 | 42篇 |
1997年 | 81篇 |
1996年 | 59篇 |
1995年 | 44篇 |
1994年 | 58篇 |
1993年 | 46篇 |
1992年 | 40篇 |
1991年 | 37篇 |
1990年 | 46篇 |
1989年 | 33篇 |
1988年 | 44篇 |
1987年 | 31篇 |
1986年 | 27篇 |
1985年 | 15篇 |
1984年 | 21篇 |
1983年 | 17篇 |
1982年 | 28篇 |
1981年 | 22篇 |
1980年 | 21篇 |
1979年 | 26篇 |
1978年 | 13篇 |
1977年 | 19篇 |
1976年 | 17篇 |
1975年 | 13篇 |
1972年 | 11篇 |
1971年 | 9篇 |
1963年 | 14篇 |
1959年 | 76篇 |
1958年 | 135篇 |
1957年 | 150篇 |
1956年 | 146篇 |
1955年 | 120篇 |
1954年 | 144篇 |
1949年 | 43篇 |
1948年 | 45篇 |
排序方式: 共有2181条查询结果,搜索用时 15 毫秒
1.
Reliable discrimination between sinus tachycardia (ST) and pathologic tachycardia has been a major problem for automatic implantable antitachycardia devices. In patients whose sinus response to activity is as rapid or faster than their pathologic tachycardia (rate crossover), these unsophisticated devices deliver the programmed tachycardia response to either the pathologic or sinus tachycardia. Over a one-year period, 50 Intermedics Intertach Model 262–12 antitachycardia pulse generators were implanted to evaluate the specificity of a new group of tachycardia recognition algorithms. Patients were subjected to exercise testing and noninvasive programmed stimulation to demonstrate the efficacy of this new approach. The five recognition algorithms tested were various combinations of the following criteria: high rate HR), sudden onset (SO), rate stability (RS), and sustained high rate (SHR). False positive rates (tachycardia response inappropriately triggered by ST) were as follows: HR (93%); HR + SO (3%); HR + RS (63%); HR + (RS or SHR) (87%); HR + HS + SO (8%). Pair-wise significance testing between HR only and HR + SO (p < 0.001), HR + RS (p = 0.01) and HR + SO + RS (p < 0.001), demonstrated a significant reduction in the rate of false positives through the use of the sudden onset and rate stability criteria in concert with the standard high rate criterion. 相似文献
2.
3.
4.
5.
6.
7.
8.
BERNHARD FREY MICHAEL WUTTE RUDOLF BERGER CLEANTHIS IOANNIDES MARTIN HÜLSMANN BRIGITTE STANEK RICHARD PACKER 《Pacing and clinical electrophysiology : PACE》1995,18(1):152-158
To investigate the impact of staged therapy for advanced heart failure on therapeutic endpoints, 236 consecutive patients (coronary artery disease/dilated cardiomyopathy in 61/175 patients, left ventricular ejection fraction 14%± 5%, New York Heart Association Class IIl/IIIIV in 102/79/55 patients, respectively) with advanced heart failure were prospectively followed. One hundred thirtyseven patients enrolled from January 1989 to December 1991 were treated conventionally with digoxin, furosemide, and low dose angiotension converting enzyme (ACE) inhibition. Patients refractory to this therapy underwent urgent heart transplantation. Ninetynine patients enrolled from January 1992 to August 1993 underwent staged therapy: stage 1: maximal tolerated ACE inhibition; stage 2: therapy with PGE1 for preand afterload reduction to achieve hemodynamic stabilization; or stage 3: refractory patients bridged to heart transplantation with continuous outpatient dobutamine. Sudden death was defined as death within 1 hour of symptoms if heart failure symptoms remained stable over the previous 7 days. Conventionally treated patients were followed for 10 ± 9 months; patients who underwent staged therapy for 9 ±5 months. In the group of patients that underwent standard therapy, 39 of 137 (28%) patients died: 5 (13%) deaths occurred suddenly, and death due to progressive pump failure occurred in the remaining 34 (87%) patients. In the group of patients that underwent staged therapy, 25 of 99 (25%) patients died: 13 (52%) deaths occurred suddenly, and 12 (48%) deaths occurred due to progressive pump failure. Thus, patients who underwent staged therapy were at increased risk for sudden death (P = 0.01, relative risk 3.4, 95% confidence interval 1.2–9.7) but were at lower risk for death from pump failure (P = 0.009, relative risk 0.44, 95% confidence interval 0.22–0.84). In patients who underwent therapy with continuous outpatient PGE1 (n = 7) or dobutamine (n= 21), risk for sudden death (P = NS by log rank test) did not increase. In conclusion, staged therapy significantly reduced death from pump failure; however, patients who could be stabilized and considered too well for heart transplantation were at increased risk for sudden death. Thus, overall survival did not improve. Of note, outpatient dobutamine did not increase the risk for sudden death. 相似文献
9.
10.
Abstract – A histometric method was applied for evaluation of root resorption in 57 experimentally replanted teeth and 22 controls. Representative axiobuccolingual sections were selected for measurement of resorptions at a magnification of × 40. The frequency of root resorption in the control teeth was low. In replanted teeth marked resorptive activity elicited by the trauma appeared after 2 wk. The extent of active resorptions increased until the third postoperative week. On an average 14% of the root periphery was affected at this stage. After the sixth postoperative week progressive cement deposition took place in the resorption lacunae. Incidental ankylosis of the periodontal membrane also occurred from this observation time but there was no increase among the long-term groups. 相似文献